Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

Autor: Pérez de Llano, Luis A., Cosío, Borja G., Domingo, Christian, Urrutia, Isabel, Bobolea, Irina, Valero, Antonio, Entrenas Costa, Luis M., Quirce, Santiago, Barranco, Pilar, Marina Malanda, Nuria, Andrés, Luis Prieto, Alvarez-Gutiérrez, Francisco J.
Zdroj: In The Journal of Allergy and Clinical Immunology: In Practice September-October 2019 7(7):2277-2283
Databáze: ScienceDirect